PhynovaPhynovaPhynovaPhynova
  • Home
  • About us
    • History
    • Team
      • Board of Directors
      • Management
    • Geographical Presence
    • Careers
  • Products
    • Reducose®
      • Reducose® inside!
      • Protocepts
      • Science News
      • Scientific References
      • Webinars
    • Phynova Joint and Muscle Pain Relief Tablets™
    • Pipeline
  • News
  • Contact us
  • Buy Phynova Joint Pain Relief
  • The Health Blog

Blog

Home Archive by category "2022"

Phynova Enters Strategic Partnership with Nutraconnect for critical markets and customers in Asia Pacific Region

By Site Admin | 2022 | Comments are Closed | 5 September, 2022 | 0

Oxfordshire-UK, Singapore – September 1st 2022 Phynova Group Ltd announces a new strategic partnership with Singapore-based Nutraconnect Pte, Ltd. to introduce its innovative, scientifically backed nutraceutical ingredient Reducose® to critical markets in Asia namely Indonesia & Thailand. This strategic partnership will also aim to take Reducose to certain Key marquee brands in the APAC region.Read more

7th clinical trial for Reducose®: new evidence published by Nestlé

By Site Admin | 2022 | Comments are Closed | 6 July, 2022 | 0

Nestlé have published results from a clinical trial evaluating the effect of Reducose® on glucose response following a complete meal. In the study, 30 healthy individuals consumed either 250mg of Reducose® prior to a meal or 250mg Reducose® mixed directly into the meal, with blood glucose measurements recorded every 10 minutes using an Abbott FreestyleRead more

Phynova and Ingredients Plus announce a distribution partnership to promote Reducose® in Oceania

By Site Admin | 2022 | Comments are Closed | 21 June, 2022 | 0

Oxford (UK) and Sydney (AU), June 2022 Phynova Group Ltd and Ingredients Plus announce a distribution partnership for Reducose®, for use in Supplement applications to customers in Oceania. Reducose® is Phynova’s patented and clinically researched White Mulberry leaf extract that supports significant lowering of post-meal blood sugar and insulin response as well as enabling foodRead more

Phynova and InVita reach an exclusive distribution agreement to promote Reducose® in Russia, Kazakhstan, Belarus, and Armenia

By Site Admin | 2022, News Stories | Comments are Closed | 10 October, 2021 | 0

Oxford, Moscow, January 2022 PHYNOVA Group Ltd (“Phynova”) and INVITA-Trade (“InVita”) announce an exclusive distribution agreement for Reducose®, for use in Food and Supplement applications to customers in Russia, Kazakhstan, Belarus, and Armenia. Reducose® is Phynova’s patented and clinically researched White Mulberry leaf extract that supports significant lowering of post-meal blood sugar and insulin responseRead more

Contact us

For any queries
Call: +44 (0)1993 880 700
Skype: Phynova Group Ltd
FaceTime: phynova@icloud.com
Email: info@phynova.com

Products

products-icon

Reducose®

Learn more

Joint & Muscle
Relief Tablets™

Learn more

Stay in touch

We would like to hear your views and share
ours with you.
KEEP CONNECTED
© Phynova Group Ltd | Terms of Use | Privacy Policy | Site Map | Website by Wiseserve Ltd
  • Home
  • About us
    • History
    • Team
      • Board of Directors
      • Management
    • Geographical Presence
    • Careers
  • Products
    • Reducose®
      • Reducose® inside!
      • Protocepts
      • Science News
      • Scientific References
      • Webinars
    • Phynova Joint and Muscle Pain Relief Tablets™
    • Pipeline
  • News
  • Contact us
  • Buy Phynova Joint Pain Relief
  • The Health Blog
Phynova